Pancreas Carcinoma Antigen Fused to Invariant Chain Elicits T-Cell Response and Tumor Growth Inhibition
Srinivas Nagaraj(University of South Florida), Ingo G.H. Schmidt‐Wolf(University Hospital Bonn), Juergen Neumann(University of Bonn), Carsten Ziske(University of Bonn), Susanne Frank(University Hospital Bonn), Bettina Winzen(University of Bonn), Norbert Koch(University of Bonn), Elisabeth Sievers(Karolinska University Hospital)
Cited by 7
Related Papers
MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis
|The Journal of Experimental Medicine|2007|647
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer
|Clinical Cancer Research|2016|113
SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma
|Oncogene|2013|95
Activated γδ T cells express the natural cytotoxicity receptor natural killer p44 and show cytotoxic activity against myeloma cells
|Clinical & Experimental Immunology|2006|90